Navoximod clinical trials
Also written GDC-0919.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2014
How each study uses navoximod is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
3 studies that test it; most in 2014 (1)
| Year | Studies |
|---|---|
| 2014 | 1 |
| 2015 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
Who runs them
Industry 2 · Other 1
Genentech, Inc. (2) · Luke, Jason, MD (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses navoximod is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Safety of Navoximod and NLG802 With Stereotactic Body Radiotherapy (SBRT) Treatment of Advanced Solid TumorsWithdrawnPhase 1Luke, Jason, MDNCT05469490Written as navoximodHow we know
- A Study of GDC-0919 and Atezolizumab Combination Treatment in Participants With Locally Advanced or Metastatic Solid TumorsCompletedPhase 1Genentech, Inc.NCT02471846Written as GDC-0919How we know
- Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Advanced Solid TumorsCompletedPhase 1Genentech, Inc.NCT02048709Written as GDC-0919How we know
Codes
What other systems call navoximod · ClinicalTrials.gg INT001227
- MeSH (NLM) C000655606navoximodOne source NLM
- UNII (FDA) 926SHL95NCNAVOXIMODConfirmed FDA, NLM, Wikidata
- Wikidata Q27271481navoximodConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C113793NavoximodOne source FDA
- DrugBank DB15439One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000655606 | navoximod | One source NLM |
| UNII (FDA) | 926SHL95NC | NAVOXIMOD | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27271481 | navoximod | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C113793 | Navoximod | One source FDA |
| DrugBank | DB15439 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.